| The application of modeling and prediction to the formation and stability of amorphous solid dispersions K DeBoyace, PLD Wildfong Journal of Pharmaceutical Sciences 107 (1), 57-74, 2018 | 93 | 2018 |
| Tunable thermoassociation of binary guanosine gels Y Yu, D Nakamura, K DeBoyace, AW Neisius, LB McGown The Journal of Physical Chemistry B 112 (4), 1130-1134, 2008 | 87 | 2008 |
| Modeling and prediction of drug dispersability in polyvinylpyrrolidone-vinyl acetate copolymer using a molecular descriptor K DeBoyace, IS Buckner, Y Gong, TR Ju, PLD Wildfong Journal of Pharmaceutical Sciences 107 (1), 334-343, 2018 | 15 | 2018 |
| Raman spectroscopy for the process analysis of the manufacturing of a suspension metered dose inhaler J Butz, L de la Cruz, J DiTonno, K DeBoyace, G Ewing, B Donovan, ... Journal of pharmaceutical and biomedical analysis 54 (5), 1013-1019, 2011 | 15 | 2011 |
| Interpreting the physicochemical meaning of a molecular descriptor which is predictive of amorphous solid dispersion formation in polyvinylpyrrolidone vinyl acetate K DeBoyace, M Bookwala, IS Buckner, D Zhou, PLD Wildfong Molecular Pharmaceutics 19 (1), 303-317, 2021 | 10 | 2021 |
| Predicting density of amorphous solid materials using molecular dynamics simulation M Bookwala, K DeBoyace, IS Buckner, PLD Wildfong AAPS PharmSciTech 21, 1-11, 2020 | 9 | 2020 |
| Differential scanning calorimetry isothermal hold times can impact interpretations of drug-polymer dispersability in amorphous solid dispersions K DeBoyace, C Zdaniewski, PLD Wildfong Journal of pharmaceutical and biomedical analysis 150, 43-50, 2018 | 7 | 2018 |
| Applications of dynamic mechanical analysis in the engineering of amorphous solid dispersions AT Ojo, PI Lee Pharmaceutical Fronts 2 (01), e55-e63, 2020 | 5 | 2020 |
| Metronidazole crystal patterns formed during the metamorphosis of topical carbopol gels. S Ajjarapu, K DeBoyace, S Sarabu, VK Shankar, S Rangappa, ... International Journal of Pharmaceutical Excipients 14 (1), 44-56, 2023 | 2 | 2023 |
| Modeling and Prediction of Amorphous Solid Dispersion Formation Using a Molecular Descriptor K DeBoyace Duquesne University, 2019 | 2 | 2019 |
| Crystal structure of tert-butyl 4-[4-(4-fluorophenyl)-2-methylbut-3-yn-2-yl] piperazine-1-carboxylate A Gumireddy, K DeBoyace, A Rupprecht, M Gupta, S Patel, PT Flaherty, ... Acta Crystallographica Section E: Crystallographic Communications 77 (4 …, 2021 | 1 | 2021 |
| Solid forms of a cdk2 inhibitor CAO Fengjuan, KF Deboyace, M Heberlein US Patent App. 18/268,959, 2024 | | 2024 |
| Understanding the Influence of API Conformations on Amorphous Dispersion Formation Potential Predictions using the R3m Molecular Descriptor K DeBoyace, M Bookwala, D Zhou, IS Buckner, PLD Wildfong Molecular Pharmaceutics 21 (2), 770-780, 2024 | | 2024 |
| Drug Phase Transformation and Water Redistribution during Continuous Tablet Manufacturing: A Case Study of Carbamazepine Dihydrate B Munjal, K DeBoyace, F Cao, JF Krzyzaniak, KK Arora, ... Molecular pharmaceutics 20 (7), 3427-3437, 2023 | | 2023 |
